Genetic determinants of TAC chemotherapy response in triple negative breast cancer patients
Triple negative breast cancer (TNBC), one of the breast cancer subtypes is characterised by aggresive phenotype, high rates of recurrence and poor prognosis and is an important clinical challenge due to lack of specific targeted therapy. Although, TNBC patients are treated with taxane, adriamycin...
| المؤلف الرئيسي: | |
|---|---|
| التنسيق: | أطروحة |
| اللغة: | الإنجليزية |
| منشور في: |
2018
|
| الموضوعات: | |
| الوصول للمادة أونلاين: | http://eprints.usm.my/45719/ |
| Abstract | Abstract here |